Owens & Minor(US:OMI)2025-02-28 11:35Financial Projections - Preliminary revenue for full year 2024 is expected to be between $10.67 billion and $10.70 billion, with a net loss projected between $(378) million and $(355) million[6]. - Adjusted EBITDA for full year 2024 is anticipated to be between $520 million and $525 million, with adjusted EPS ranging from $1.50 to $1.53[6]. - Cash provided by operating activities for full year 2024 is expected to be between $160 million and $165 million[6]. - Gross capital expenditures for full year 2024 are projected to be between $228 million and $233 million[6]. Debt Management - The company plans to raise additional debt to finance the acquisition of Rotech Healthcare Holdings, expected to close in the first half of 2025[3]. - Total debt is projected to be between $1.854 billion and $1.859 billion, with net debt between $1.805 billion and $1.810 billion[6]. - The company reduced total debt by over $240 million during 2024 despite significant reinvestment in the business[4]. Segment Performance - The Patient Direct segment showed solid mid-single digit growth for the full year 2024, with even higher growth in key categories[4]. Impairment Charges - A non-cash goodwill impairment charge of approximately $310 million is expected, impacting net loss per share by about $(4.00)[7]. Upcoming Events - The investor conference call for the fourth quarter and full year 2024 results is scheduled for February 28, 2025[9].